Cite
HARVARD Citation
Wehling, C. et al. (n.d.). Monitoring of complement activation biomarkers and eculizumab in complement‐mediated renal disorders. Clinical and experimental immunology. pp. 304-315. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wehling, C. et al. (n.d.). Monitoring of complement activation biomarkers and eculizumab in complement‐mediated renal disorders. Clinical and experimental immunology. pp. 304-315. [Online].